학술논문
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Document Type
Article
Author
Facon, T.; Manier, S.; Cook, G.; Usmani, S.Z.; Hulin, C.; Kumar, S.; Plesner, T.; Touzeau, C.; Bahlis, N.J.; Basu, S.; Nahi, H.; Goldschmidt, H.; Quach, H.; Mohty, M.; Venner, C.P.; Weisel, K.; Raje, N.; Hebraud, B.; Belhadj-Merzoug, K.; Benboubker, L.; Decaux, O.; Caillot, D.; Ukropec, J.; Pei, H.; Van Rampelbergh, R.; Uhlar, C.M.; Kobos, R.; Zweegman, S.
Source
In: Leukemia . (Leukemia, April 2022, 36(4):1066-1077)
Subject
Language
English
ISSN
14765551
08876924
08876924